{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:45:13Z","timestamp":1790707513178,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The diagnostic yield of TORCH screening for obstetrical indications is unclear. We evaluated TORCH testing results among women with intrauterine growth restriction (IUGR), polyhydramnios and oligohydramnios; and associations with congenital infections in neonates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>This retrospective single-center study included all the women diagnosed with IUGR, polyhydramnios or oligohydramnios who underwent serological TORCH testing during 2010\u20132019. TORCH screening included Toxoplasma, cytomegalovirus (CMV), rubella IgM and IgG. The data, which were cross-referenced with data of neonates with congenital TORCH infections during the same period, included indications for neonatal testing, sonographic findings and neonatal ophthalmologic and hearing findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result:<\/jats:title>\n            <jats:p>Six women of 771 (0.8%) were diagnosed with primary TORCH infection: 4 (0.5%) with toxoplasmosis, and 2 (0.3%) with CMV. None had a confirmed congenital infection. The rates of positive maternal TORCH screening in IUGR and polyhydramnios were 2.1% and 0.6%, respectively. Maternal TORCH infection was not identified in any woman with oligohydramnios or severe polyhydramnios. None of the neonates with congenital infection were screened for TORCH during pregnancy due to polyhydramnios, oligohydramnios or IUGR. Among the neonates with congenital CMV, the most common indication for performing neonatal CMV polymerase chain reaction was suspected primary maternal infection during pregnancy due to symptomatic CMV. No incidences of congenital rubella were noted in the last decade in our medical center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our results suggest that routine TORCH screening in pregnancies complicated with IUGR, polyhydramnios or oligohydramnios should be avoided. Suggestive maternal symptoms and specific fetal sonographic features should prompt testing for CMV and Toxoplasma infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004107","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T21:04:49Z","timestamp":1695157489000},"page":"69-73","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["The Utility of Maternal TORCH Screening Due to Obstetrical Indications in Detecting Congenital Infections: A Retrospective Observational Study"],"prefix":"10.1097","volume":"43","author":[{"given":"Raneen","family":"Abu Shqara","sequence":"first","affiliation":[{"name":"Obstetrics and Gynecology department, Galilee Medical Center, Nahariya, Israel"},{"name":"Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shany","family":"Or","sequence":"additional","affiliation":[{"name":"Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Abu Zraki","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology department, Galilee Medical Center, Nahariya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeries","family":"Rizik","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology department, Galilee Medical Center, Nahariya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Glikman","sequence":"additional","affiliation":[{"name":"Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagai","family":"Rechnitzer","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology department, Galilee Medical Center, Nahariya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Lowenstein","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology department, Galilee Medical Center, Nahariya, Israel"},{"name":"Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2060-3234","authenticated-orcid":false,"given":"Maya","family":"Frank Wolf","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology department, Galilee Medical Center, Nahariya, Israel"},{"name":"Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clp.2014.11.001","article-title":"TORCH infections.","volume":"42","author":"Neu","year":"2015","journal-title":"Clin Perinatol"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/01443615.2013.872609","article-title":"TORCH screening in pregnancy. Where are we now? An audit of use in a tertiary level centre.","volume":"34","author":"Halawa","year":"2014","journal-title":"J Obstet Gynaecol"},{"key":"R3-20250614","first-page":"QR01","article-title":"Pregnancy outcomes in isolated oligohydramnios during second trimester: a case series.","volume":"11","author":"Taneja","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/pd.6073","article-title":"A systematic review of maternal TORCH serology as a screen for suspected fetal infection.","volume":"42","author":"Fitzpatrick","year":"2022","journal-title":"Prenat Diagn"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3109\/14767058.2011.622002","article-title":"TORCH screening in polyhydramnios: an observational study.","volume":"25","author":"Fayyaz","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/pd.4769","article-title":"Prevalence of a positive TORCH and parvovirus B19 screening in pregnancies complicated by polyhydramnios.","volume":"36","author":"Pasquini","year":"2016","journal-title":"Prenat Diagn"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-2000-9288","article-title":"Yield and costs of screening growth-retarded infants for torch infections.","volume":"17","author":"Khan","year":"2000","journal-title":"Am J Perinatol"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/archdischild-2012-303327","article-title":"How to use neonatal TORCH testing.","volume":"98","author":"de Jong","year":"2013","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/pd.1242","article-title":"TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom.","volume":"25","author":"Abdel-Fattah","year":"2005","journal-title":"Prenat Diagn"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1136\/fn.88.5.F371","article-title":"Urine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infection.","volume":"88","author":"Schlesinger","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1086\/590149","article-title":"Management of Toxoplasma gondii infection during pregnancy.","volume":"47","author":"Montoya","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R12-20250614","first-page":"518","article-title":"Fetal growth curves [1].","volume":"8","author":"Dollberg","year":"2006","journal-title":"IMAJ"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"CMPed.S40070","DOI":"10.4137\/CMPed.S40070","article-title":"Intrauterine growth restriction: antenatal and postnatal aspects.","volume":"10","author":"Sharma","year":"2016","journal-title":"Clin Med Insights Pediatr"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/01.ogx.0000290349.58707.e0","article-title":"A review of idiopathic hydramnios and pregnancy outcomes.","volume":"62","author":"Magann","year":"2007","journal-title":"Obstet Gynecol Surv"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2018.07.016","article-title":"SMFM Consult Series #46: evaluation and management of polyhydramnios.","volume":"219","author":"Dashe","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3345\/kjp.2018.61.4.114","article-title":"TORCH (Toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus) screening of small for gestational age and intrauterine growth restricted neonates: Efficacy study in a single institute in Korea.","volume":"61","author":"Chung","year":"2018","journal-title":"Korean J Pediatr"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.05.010","article-title":"Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction.","volume":"223","author":"S Martins","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/s41372-021-01157-9","article-title":"Primary cytomegalovirus infection during pregnancy and congenital infection: a population-based, mother\u2013child, prospective cohort study.","volume":"41","author":"Shimada","year":"2021","journal-title":"J Perinatol"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/21645515.2015.1032489","article-title":"Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.","volume":"11","author":"Levine","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/v13050866","article-title":"Low maternal immunoglobulin G avidity and single parity as adverse implications of human cytomegalovirus vertical transmission in pregnant women with immunoglobulin M positivity.","volume":"13","author":"Kaneko","year":"2021","journal-title":"Viruses"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fped.2020.00013","article-title":"Congenital cytomegalovirus infection: a narrative review of the issues in screening and management from a panel of European experts.","volume":"8","author":"Lazzarotto","year":"2020","journal-title":"Front Pediatr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:46Z","timestamp":1749945646000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004107","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,2]]}}}